Lilly Pill Reduces Genetic Cholesterol by Nearly 86% in Trial
Lilly’s Breakthrough in Cholesterol Treatment Eli Lilly’s experimental oral medication, muvalaplin, has shown significant promise in treating an inherited form of high cholesterol, specifically targeting lipoprotein(a),...